Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 2.0
Saved in:
| Other Authors: | , , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | No linguistic content |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_114009 | ||
| 005 | 20230911 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230911s2023 xx |||||o ||| 0|||| d | ||
| 020 | |a books978-3-0365-8657-1 | ||
| 020 | |a 9783036586564 | ||
| 020 | |a 9783036586571 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-8657-1 |c doi | |
| 041 | 0 | |a zxx | |
| 042 | |a dc | ||
| 072 | 7 | |a MBG |2 bicssc | |
| 100 | 1 | |a Kutner, Andrzej |4 edt | |
| 700 | 1 | |a Brown, Geoffrey |4 edt | |
| 700 | 1 | |a Kallay, Enikö |4 edt | |
| 700 | 1 | |a Kutner, Andrzej |4 oth | |
| 700 | 1 | |a Brown, Geoffrey |4 oth | |
| 700 | 1 | |a Kallay, Enikö |4 oth | |
| 245 | 1 | 0 | |a Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 2.0 |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (494 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 650 | 7 | |a Medical equipment & techniques |2 bicssc | |
| 653 | |a drug design and discovery | ||
| 653 | |a drug&ndash | ||
| 653 | |a protein interactions | ||
| 653 | |a drug response | ||
| 653 | |a drug solubility | ||
| 653 | |a antimicrobial drugs | ||
| 653 | |a antiviral drugs | ||
| 653 | |a antibiotics | ||
| 653 | |a anticancer drugs | ||
| 653 | |a cancer prevention | ||
| 653 | |a molecular modeling | ||
| 653 | |a molecular mechanisms | ||
| 653 | |a crystallography | ||
| 653 | |a preclinical study | ||
| 653 | |a pharmacokinetics | ||
| 653 | |a pharmacodynamics | ||
| 653 | |a pharmacognosy | ||
| 653 | |a nuclear receptors | ||
| 653 | |a receptor agonist and antagonist | ||
| 653 | |a activity profiling, markers and diagnostics | ||
| 653 | |a drug carriers | ||
| 653 | |a dosage form | ||
| 653 | |a nanoparticles | ||
| 653 | |a dissolution testing | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7854 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/114009 |7 0 |z DOAB: description of the publication |